Biomea Fusion, Inc. (BMEA) income statement
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.53+0.04 (+8.61%)
Close on Nov 18, 2026Market cap $38.42MP/E –Yield –
Biomea Fusion, Inc. financial ratios
See a number that looks wrong?
Close on Nov 18, 2026Market cap $38.42MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Returns on capital | ||||||||
| Return on equity | -152.4% | -125.4% | -84.4% | -57.0% | -45.2% | -206.8% | 843.7% | – |
| Return on assets | -89.2% | -98.9% | -71.2% | -52.0% | -33.5% | -8.5% | – | – |
| Return on tangible assets | -89.2% | -98.9% | -71.2% | -52.0% | -33.5% | -8.5% | – | – |
| Return on capital employed | -158.0% | -122.4% | -87.8% | -57.4% | -34.4% | -8.7% | – | – |
| NOPAT | -$65.97M | -$113.82M | -$99.65M | -$66.07M | -$32.92M | -$4.21M | -$944.05K | – |
| Cash flow quality | ||||||||
| OCF / Net income | 1.14 | 0.87 | 0.82 | 0.76 | 0.85 | 0.84 | 1.07 | – |
| FCF / OCF | – | 100.3% | 103.5% | 101.7% | 108.9% | 101.1% | – | – |
| FCF / Net income | – | 0.87 | 0.85 | 0.78 | 0.93 | 0.85 | – | – |
| Unlevered free cash flow | – | -$120.26M | -$99.96M | -$63.45M | -$38.61M | -$4.51M | – | – |
| Levered free cash flow | – | -$120.26M | -$99.96M | -$63.45M | -$38.61M | -$4.51M | – | – |
| Efficiency | ||||||||
| CapEx to OCF | – | -0.30% | -3.5% | -1.7% | -8.9% | -1.1% | – | – |
| Liquidity | ||||||||
| Current ratio | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 | 38.43 | – | – |
| Quick ratio | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 | 38.43 | – | – |
| Cash ratio | 5.03 | 2.71 | 7.74 | 5.94 | 37.50 | 38.11 | – | – |
| Working capital | $46.95M | $46.66M | $156.32M | $98.72M | $171.92M | $60.60M | – | – |
| Net current asset value | $29.03M | $39.97M | $148.49M | $97.05M | $169.64M | $60.60M | – | – |
| Leverage | ||||||||
| Assets to equity | 1.98 | 1.55 | 1.18 | 1.19 | 1.04 | 12.10 | – | – |
| Per share | ||||||||
| EPS (basic) | -1.18 | -3.83 | -3.44 | -2.80 | -1.74 | -0.51 | -0.20 | – |
| EPS (diluted) | -1.18 | -3.83 | -3.44 | -2.80 | -1.74 | -0.51 | -0.20 | – |
| Book value per share | 0.41 | 1.42 | 4.72 | 3.67 | 6.14 | 0.43 | -0.0035 | – |
| Tangible book value per share | 0.41 | 1.42 | 4.72 | 3.67 | 6.14 | 0.43 | -0.0035 | – |
| Cash per share | 0.77 | 1.62 | 4.93 | 3.84 | 5.97 | 5.16 | 0.04 | – |
| Operating cash flow per share | -0.97 | -3.30 | -2.69 | -2.11 | -1.22 | -0.37 | -0.21 | – |
| Free cash flow per share | – | -3.31 | -2.79 | -2.15 | -1.33 | -0.38 | – | – |
| CapEx per share | – | 0.0100 | 0.09 | 0.03 | 0.11 | 0.0043 | – | – |
| Valuation at period end | ||||||||
| Market cap | $73.79M | $140.60M | $518.35M | $247.75M | $216.36M | – | – | – |
| Enterprise value | $27.15M | $52.65M | $319.26M | $114.29M | $26.96M | – | – | – |
| P/B | 2.5x | 2.7x | 3.1x | 2.3x | 1.2x | – | – | – |
| P/TBV | 2.5x | 2.7x | 3.1x | 2.3x | 1.2x | – | – | – |
| P/OCF | -1.0x | -1.2x | -5.4x | -4.0x | -6.1x | – | – | – |
| EV/OCF | -0.4x | -0.4x | -3.3x | -1.8x | -0.8x | – | – | – |
| Earnings yield | -83.7% | -98.5% | -22.6% | -33.0% | -19.2% | – | – | – |
| FCF yield | – | -85.5% | -19.3% | -25.6% | -17.8% | – | – | – |
| Per employee | ||||||||
| Total employees | 41 | 106 | 103 | 83 | 51 | 51 | 51 | 51 |
| Operating profit per employee | -$2.04M | -$1.36M | -$1.22M | -$1.01M | -$817.00K | -$104.45K | -$23.43K | – |
| Net income per employee | -$1.51M | -$1.31M | -$1.14M | -$985.88K | -$815.04K | -$104.39K | -$23.49K | – |
| Free cash flow per employee | – | -$1.13M | -$970.50K | -$764.42K | -$757.04K | -$88.43K | – | – |
| Growth | ||||||||
| EBIT 1Y growth | 42.0% | -14.2% | -50.8% | -100.7% | -682.2% | -345.8% | – | – |
| Net income 1Y growth | 55.4% | -18.1% | -43.3% | -96.9% | -680.7% | -344.4% | – | – |
| Diluted EPS 1Y growth | 69.2% | -11.3% | -22.9% | -60.9% | -241.2% | -155.0% | – | – |
| Operating cash flow 1Y growth | 41.3% | -24.1% | -54.8% | -76.1% | -694.8% | -248.6% | – | – |
| Free cash flow 1Y growth | – | -20.3% | -57.6% | -64.3% | -756.1% | – | – | – |
| CapEx 1Y growth | – | -89.3% | 227.2% | -67.5% | 6,117.6% | – | – | – |
| CapEx 3Y CAGR | – | -51.5% | 304.3% | – | – | – | – | – |
| Total assets 1Y growth | -26.7% | -60.0% | 54.6% | -30.4% | 197.0% | – | – | – |
| Total assets 3Y CAGR | -23.2% | -24.5% | 47.3% | – | – | – | – | – |
| Total assets 5Y CAGR | -1.3% | – | – | – | – | – | – | – |
| Total equity 1Y growth | -42.7% | -69.5% | 55.9% | -39.3% | 3,358.8% | 24,714.3% | 92.0% | – |
| Total equity 3Y CAGR | -35.2% | -33.9% | 219.9% | – | – | – | – | – |
| Total equity 5Y CAGR | 41.7% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.